First Turn Management »

Miragen Therapeutics shares owned by First Turn Management

Quarter-by-quarter ownership of Miragen Therapeutics (VRDN) shares owned by First Turn Management from 13F filings

Historical chart of First Turn Management investment in Miragen Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Miragen Therapeutics held by First Turn Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Miragen Therapeutics by First Turn Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $22M 691k 31.12

More positions owned by First Turn Management

Abivax Sa Sponsored Ads (ABVX)
Revolution Medicines (RVMD)
Insmed Com Par $.01 (INSM)
Bridgebio Pharma (BBIO)
Mirum Pharmaceuticals (MIRM)
Axsome Therapeutics (AXSM)
Nuvalent Inc-a (NUVL)
Xenon Pharmaceuticals (XENE)
Apogee Therapeutics (APGE)
Terns Pharmaceuticals (TERN)
Newamsterdam Pharma Company Ordinary Shares (NAMS)
United Therapeutics Corporation (UTHR)
Vera Therapeutics Cl A (VERA)
Cogent Biosciences (COGT)
Ascendis Pharma A/s Sponsored Adr (ASND)

View all positions for First Turn Management

Top funds holding Miragen Therapeutics

FMR
BlackRock
Vanguard Group
Bellevue Group
Fairmount Funds Management
VR Adviser
State Street Corporation
Deep Track Capital
Novo A/S
Geode Capital Management
Alliancebernstein
Tang Capital Management
Eversept Partners
Fisher Investments
Baker Bros. Advisors

View all funds holding Miragen Therapeutics